ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2954

The Amino Acid Positions 11, 13 and 26 of HLA-DR Beta Chain 1 Explain the Majority of the Association Between Systemic Lupus Erythematosus and the Major Histocompatibility Complex Locus

Kwangwoo Kim1,2,3, So-Young Bang4, Hye-Soon Lee4, Yukinori Okada2,3,5, Woei-Yuh Saw6, Paul IW. de Bakker2,3,7, Yik-Ying Teo6,8, Soumya Raychaudhuri2,9,10 and Sang-Cheol Bae1, 1Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 2Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 3Broad Institute, Cambridge, MA, 4Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 5Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 6National University of Singapore, Singapore, Singapore, 7Department of Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands, 8Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore, 9Broad Institute of MIT and Harvard, Cambridge, MA, 10Manchester Academic Health Sciences Centre, Manchester, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Human leukocyte antigens (HLA) and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics, Genomics and Proteomics II: Genetics of Autoimmunity

Session Type: Abstract Submissions (ACR)

Background/Purpose: Genetic association of the major histocompatibility complex (MHC) locus is well-established in systemic lupus erythematosus (SLE), but the causal functional variants in this region remain yet to be identified.  This study aimed to examine the contribution of amino acid variants in major HLA genes (HLA-A, -B, -C, -DPA1, -DPB1, -DQA1, -DQB1 and -DRB1) to SLE susceptibility and dissect the association signals within the extended MHC locus.

Methods: We inferred HLA classical alleles, amino acid residues and MHC SNPs from the genotyped data of 5,342 unrelated Korean subjects including 849 SLE cases and 4,493 controls.  For accurate imputation for the Korean population, we newly constructed an Asian HLA reference panel from two recent HLA reference panels from Korean (n=413; unpublished) and Southeast Asian (n=441) for use with the SNP2HLA software.  The dosage effect of binary markers on SLE risk was assessed by a logistic regression and the overall difference of amino acid residues at each amino acid position between case and control groups was examined by a log-likelihood ratio test comparing the fit between null model and full model with amino acids effects.

Results: The new Asian reference panel demonstrated a reliable imputation accuracy, showing high concordance rates between genotyped and imputed alleles of 61 East Asian HapMap3 individuals (98.5% at 2-digit resolution and 93.2% at 4-digit resolution) and a subset of the study subjects (n=1306; 97.9% at 2-digit resolution and 94.1% at 4-digit resolution at HLA-DRB1).  We found the primary association signal within HLA-DRB1.  When adjusted with all classical alleles of HLA-DRB1, no signal passed a genome-wide significance threshold in our study.  At the amino acid level, the most significant association with SLE susceptibility was mapped to the amino acid position 13 of HLA-DR beta chain 1 (HLA-DRβ1; P = 2.48×10-17).  The amino acid position 13 explained the SLE risk better than any single HLA allele or SNP.  Among six possible residues at the position 13, Arg/Tyr and Ser/His conferred the risk and protective effects on SLE susceptibility, respectively (OR=1.63, P=1.15×10-15 for Arg+Tyr and OR=0.65, P=4.15×10-14 for Ser+His).  We validated the association and residue effects at the position 13 using an independent Korean population including 105 SLE cases and 391 controls who were genotyped for HLA-DRB1.  In a conditional analysis, the position 26 was remained to be significantly associated with SLE (P = 2.42×10−9) after conditioning on the amino acid positions 13 and its tightly correlated position 11.  We observed 10 common haplotypes defined by the amino acid position 11-13-26.  The reported SLE-risk HLA-DRB1 alleles *15:01 and *03:01 belong to the SLE-risk haplotypes Pro-Arg-Phe and Ser- Ser-Tyr, respectively.

Conclusion: Our study identified the three amino acid positions 11, 13 and 26 at the antigen-binding groove of HLA-DRβ1 were responsible for most of the association between SLE and MHC.


Disclosure:

K. Kim,
None;

S. Y. Bang,
None;

H. S. Lee,
None;

Y. Okada,
None;

W. Y. Saw,
None;

P. I. de Bakker,
None;

Y. Y. Teo,
None;

S. Raychaudhuri,
None;

S. C. Bae,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-amino-acid-positions-11-13-and-26-of-hla-dr-beta-chain-1-explain-the-majority-of-the-association-between-systemic-lupus-erythematosus-and-the-major-histocompatibility-complex-locus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology